HYDROGEL À BASE DE BIOMOLÉCULES SILYLÉES POUR LA CULTURE DE CARDIOMYOCYTES ET DE CELLULES SOUCHES ET UTILISATION DE L'HYDROGEL POUR LE TRAITEMENT DE L'INSUFFISANCE CARDIAQUE

• 收藏
• 分享

专利权人:

Institut National de la Santé et de la Recherche Médicale (INSERM);CHU Nantes;Universite de Nantes

发明人:

申请号：

EP12725754.1

公开号：

EP2714891B1

申请日:

2012.06.04

申请国别(地区):

EP

年份:

2019

代理人:

摘要：

The present invention relates to the use of an hydrogel comprising silylated biomolecule for the three-dimensional culture of cardiomyocytes or stem cells which are able to differentiate into cardiomyocytes, and to an aqueous composition comprising i) cardiomyocytes or stem cells which are able to differentiate into cardiomyocytes, and ii) a hydrogel comprising silylated biomolecule, for use for treating heart failure, in particular heart failure following myocardial infarction.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/